A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D Pleasance,
R Keira Cheetham,
Philip J Stephens,
David J McBride,
Sean J Humphray,
Chris D Greenman,
Ignacio Varela,
Meng-Lay Lin,
Gonzalo R Ordóñez,
Graham R Bignell,
Kai Ye,
Julie Alipaz,
Markus J Bauer,
David Beare,
Adam Butler,
Richard J Carter,
Lina Chen,
Anthony J Cox,
Sarah Edkins,
Paula I Kokko-Gonzales,
Niall A Gormley,
Russell J Grocock,
Christian D Haudenschild,
Matthew M Hims,
Terena James,
Mingming Jia,
Zoya Kingsbury,
Catherine Leroy,
John Marshall,
Andrew Menzies,
Laura J Mudie,
Zemin Ning,
Tom Royce,
Ole B Schulz-Trieglaff,
Anastassia Spiridou,
Lucy A Stebbings,
Lukasz Szajkowski,
Jon Teague,
David Williamson,
Lynda Chin,
Mark T Ross,
Peter J Campbell,
David R Bentley,
P Andrew Futreal and
Michael R Stratton
Nature 463(7278):191 (2010)
PMID 20016485
All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic.
DOI: 10.1038/nature08658
Version: za2963e q8za7 q8zbd q8zc8 q8zd3 q8zea q8zff q8zg1